[PHARMA] QoQ Quarter Result on 30-Sep-2018 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Nov-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
30-Sep-2018 [#3]
Profit Trend
QoQ- 179.03%
YoY- 320.42%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 601,890 786,108 596,644 587,660 582,729 617,923 613,196 -1.23%
PBT 12,481 30,243 11,940 17,603 11,970 28,707 19,866 -26.70%
Tax -3,219 -10,595 -7,370 -2,298 -6,204 -11,118 2,222 -
NP 9,262 19,648 4,570 15,305 5,766 17,589 22,088 -44.06%
-
NP to SH 9,281 19,617 4,437 15,051 5,394 17,586 21,700 -43.32%
-
Tax Rate 25.79% 35.03% 61.73% 13.05% 51.83% 38.73% -11.18% -
Total Cost 592,628 766,460 592,074 572,355 576,963 600,334 591,108 0.17%
-
Net Worth 518,564 528,825 509,862 522,618 519,642 524,838 526,888 -1.05%
Dividend
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Div 6,514 15,630 5,202 13,000 10,392 12,991 15,573 -44.15%
Div Payout % 70.19% 79.68% 117.26% 86.38% 192.67% 73.87% 71.77% -
Equity
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Net Worth 518,564 528,825 509,862 522,618 519,642 524,838 526,888 -1.05%
NOSH 261,229 260,505 260,505 260,505 259,821 259,821 259,821 0.36%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin 1.54% 2.50% 0.77% 2.60% 0.99% 2.85% 3.60% -
ROE 1.79% 3.71% 0.87% 2.88% 1.04% 3.35% 4.12% -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
RPS 230.98 301.76 229.36 226.02 224.28 237.83 236.25 -1.49%
EPS 3.56 7.53 1.71 5.79 2.08 6.77 8.36 -43.48%
DPS 2.50 6.00 2.00 5.00 4.00 5.00 6.00 -44.30%
NAPS 1.99 2.03 1.96 2.01 2.00 2.02 2.03 -1.32%
Adjusted Per Share Value based on latest NOSH - 260,505
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
RPS 41.76 54.54 41.40 40.77 40.43 42.87 42.55 -1.24%
EPS 0.64 1.36 0.31 1.04 0.37 1.22 1.51 -43.66%
DPS 0.45 1.08 0.36 0.90 0.72 0.90 1.08 -44.30%
NAPS 0.3598 0.3669 0.3538 0.3626 0.3605 0.3642 0.3656 -1.06%
Price Multiplier on Financial Quarter End Date
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Date 28/06/19 29/03/19 31/12/18 28/09/18 29/06/18 30/03/18 29/12/17 -
Price 2.84 2.27 2.78 2.89 2.88 4.28 4.60 -
P/RPS 1.23 0.75 1.21 1.28 1.28 1.80 1.95 -26.51%
P/EPS 79.74 30.14 162.99 49.93 138.73 63.23 55.02 28.15%
EY 1.25 3.32 0.61 2.00 0.72 1.58 1.82 -22.20%
DY 0.88 2.64 0.72 1.73 1.39 1.17 1.30 -22.96%
P/NAPS 1.43 1.12 1.42 1.44 1.44 2.12 2.27 -26.57%
Price Multiplier on Announcement Date
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Date 23/08/19 16/05/19 21/02/19 19/11/18 17/08/18 16/05/18 27/02/18 -
Price 2.66 2.36 2.76 3.09 3.11 4.07 4.04 -
P/RPS 1.15 0.78 1.20 1.37 1.39 1.71 1.71 -23.29%
P/EPS 74.69 31.34 161.81 53.38 149.80 60.13 48.32 33.79%
EY 1.34 3.19 0.62 1.87 0.67 1.66 2.07 -25.22%
DY 0.94 2.54 0.72 1.62 1.29 1.23 1.49 -26.50%
P/NAPS 1.34 1.16 1.41 1.54 1.56 2.01 1.99 -23.23%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment